NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 132 filers reported holding NOVOCURE LTD in Q1 2018. The put-call ratio across all filers is 0.13 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,078,796 | -66.7% | 66,255 | -15.8% | 0.00% | -66.7% |
Q2 2023 | $3,241,251 | -36.8% | 78,665 | -8.7% | 0.01% | -40.0% |
Q1 2023 | $5,129,078 | +84.2% | 86,208 | +122.7% | 0.01% | +66.7% |
Q4 2022 | $2,784,541 | -5.2% | 38,715 | +1.1% | 0.01% | 0.0% |
Q3 2022 | $2,938,000 | +11.3% | 38,281 | +4.1% | 0.01% | +20.0% |
Q2 2022 | $2,640,000 | -14.1% | 36,762 | +0.3% | 0.01% | 0.0% |
Q1 2022 | $3,072,000 | +7.8% | 36,664 | +1.7% | 0.01% | 0.0% |
Q4 2021 | $2,851,000 | -30.9% | 36,051 | +1.5% | 0.01% | -28.6% |
Q3 2021 | $4,124,000 | -46.9% | 35,527 | +2.1% | 0.01% | -46.2% |
Q2 2021 | $7,764,000 | -29.0% | 34,801 | -58.5% | 0.01% | -31.6% |
Q1 2021 | $10,935,000 | -12.9% | 83,819 | +15.7% | 0.02% | -24.0% |
Q4 2020 | $12,559,000 | +208.7% | 72,433 | +95.5% | 0.02% | +177.8% |
Q3 2020 | $4,069,000 | +6.8% | 37,055 | -43.0% | 0.01% | +12.5% |
Q2 2020 | $3,810,000 | -22.7% | 64,971 | -9.9% | 0.01% | -38.5% |
Q1 2020 | $4,932,000 | +65.6% | 72,118 | +106.0% | 0.01% | +116.7% |
Q4 2019 | $2,978,000 | +4.5% | 35,005 | -9.5% | 0.01% | 0.0% |
Q3 2019 | $2,849,000 | +24.0% | 38,691 | +2.5% | 0.01% | +50.0% |
Q2 2019 | $2,297,000 | +28.0% | 37,747 | -0.9% | 0.00% | +33.3% |
Q1 2019 | $1,795,000 | +2428.2% | 38,072 | +1666.7% | 0.00% | – |
Q4 2018 | $71,000 | -85.3% | 2,155 | -76.6% | 0.00% | -100.0% |
Q3 2018 | $484,000 | +67.5% | 9,228 | 0.0% | 0.00% | 0.0% |
Q2 2018 | $289,000 | -42.4% | 9,228 | -59.9% | 0.00% | 0.0% |
Q1 2018 | $502,000 | -1.2% | 23,038 | -7.1% | 0.00% | 0.0% |
Q4 2017 | $508,000 | +3.3% | 24,802 | 0.0% | 0.00% | 0.0% |
Q3 2017 | $492,000 | +35.9% | 24,802 | +18.5% | 0.00% | 0.0% |
Q2 2017 | $362,000 | +352.5% | 20,926 | +100.6% | 0.00% | – |
Q4 2016 | $80,000 | – | 10,434 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Nordwand Advisors, LLC | 1,515,000 | $111,125,249 | 13.86% |
Invus Financial Advisors, LLC | 350,884 | $25,737,341 | 13.70% |
HARTLINE INVESTMENT CORP/ | 304,482 | $22,333,755 | 5.08% |
GREAT POINT PARTNERS LLC | 241,000 | $17,677,350 | 3.46% |
Tri Locum Partners LP | 72,400 | $5,311,000 | 2.15% |
Taylor Frigon Capital Management LLC | 42,061 | $3,085,174 | 1.75% |
HighVista Strategies LLC | 28,007 | $2,054,313 | 1.22% |
HAP Trading, LLC | 124,500 | $10,294 | 1.05% |
Private Harbour Investment Management & Counsel, LLC | 12,285 | $901,105 | 0.99% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 32,000 | $2,344,000 | 0.72% |